MRK in the 13F filings
Merck & Co Inc · CUSIP 58933Y105
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 6 Aug 2024
- Managers listing it
- 38
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 34 listed it in both
- Shares listed
- 266,388,281
- combined, among listed positions
- Reported value
- $33.0bn
- combined, at the quarter end
Among the 94 comparable managers: 21 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing MRK in Q2 2024
38 of 38 holders
Largest increases and reductions, by shares
Increases
- Arrowstreet Capital LPexisting position · 6,207,199 shares now+1,459,491
- Capital World Investorsexisting position · 15,271,723 shares now+1,317,706
- Two Sigma Investments LPexisting position · 1,483,102 shares now+871,699
- Jane Street Group LLCexisting position · 2,434,424 shares now+841,959
- Citadel Advisors LLCexisting position · 8,242,067 shares now+666,847
Reductions
- Wellington Management Group LLPexisting position · 72,481,979 shares now-13,866,280
- T. Rowe Price Associates Incexisting position · 24,725,061 shares now-4,914,456
- Fidelity (FMR LLC)existing position · 50,653,254 shares now-1,517,665
- MFS Investment Managementexisting position · 9,672,022 shares now-1,213,413
- Millennium Management LLCexisting position · 9,585,179 shares now-484,273
New positions and exits
New (1)
Exited (1)
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 23 | $25.9bn | n.a. | n.a. |
| Q3 2013 | 24 | $25.4bn | n.a. | n.a. |
| Q4 2013 | 23 | $27.1bn | n.a. | n.a. |
| Q1 2014 | 24 | $31.2bn | n.a. | n.a. |
| Q2 2014 | 28 | $30.6bn | n.a. | n.a. |
| Q3 2014 | 32 | $30.5bn | n.a. | n.a. |
| Q4 2014 | 30 | $28.6bn | n.a. | n.a. |
| Q1 2015 | 29 | $28.8bn | n.a. | n.a. |
| Q2 2015 | 29 | $27.1bn | n.a. | n.a. |
| Q3 2015 | 25 | $23.0bn | n.a. | n.a. |
| Q4 2015 | 28 | $23.9bn | n.a. | n.a. |
| Q1 2016 | 28 | $23.8bn | n.a. | n.a. |
| Q2 2016 | 27 | $25.9bn | n.a. | n.a. |
| Q3 2016 | 27 | $27.5bn | n.a. | n.a. |
| Q4 2016 | 26 | $24.4bn | n.a. | n.a. |
| Q1 2017 | 31 | $24.7bn | n.a. | n.a. |
| Q2 2017 | 34 | $24.0bn | n.a. | n.a. |
| Q3 2017 | 31 | $23.7bn | n.a. | n.a. |
| Q4 2017 | 32 | $20.0bn | n.a. | n.a. |
| Q1 2018 | 30 | $17.5bn | n.a. | n.a. |
| Q2 2018 | 27 | $19.3bn | n.a. | n.a. |
| Q3 2018 | 27 | $22.9bn | n.a. | n.a. |
| Q4 2018 | 26 | $24.4bn | n.a. | n.a. |
| Q1 2019 | 26 | $24.4bn | n.a. | n.a. |
| Q2 2019 | 28 | $23.3bn | n.a. | n.a. |
| Q3 2019 | 31 | $23.2bn | n.a. | n.a. |
| Q4 2019 | 34 | $24.0bn | n.a. | n.a. |
| Q1 2020 | 33 | $18.5bn | n.a. | n.a. |
| Q2 2020 | 34 | $18.6bn | n.a. | n.a. |
| Q3 2020 | 35 | $20.2bn | n.a. | n.a. |
| Q4 2020 | 34 | $19.1bn | n.a. | n.a. |
| Q1 2021 | 33 | $16.6bn | n.a. | n.a. |
| Q2 2021 | 31 | $15.1bn | n.a. | n.a. |
| Q3 2021 | 31 | $15.2bn | n.a. | n.a. |
| Q4 2021 | 26 | $15.0bn | n.a. | n.a. |
| Q1 2022 | 34 | $17.4bn | n.a. | n.a. |
| Q2 2022 | 34 | $19.0bn | n.a. | n.a. |
| Q3 2022 | 35 | $17.2bn | n.a. | n.a. |
| Q4 2022 | 35 | $25.2bn | n.a. | n.a. |
| Q1 2023 | 33 | $26.6bn | n.a. | n.a. |
| Q2 2023 | 34 | $30.1bn | n.a. | n.a. |
| Q3 2023 | 39 | $26.7bn | n.a. | n.a. |
| Q4 2023 | 41 | $29.3bn | 22 | 20 |
| Q1 2024 | 37 | $37.1bn | 21 | 19 |
| Q2 2024 | 38 | $33.0bn | 21 | 18 |
| Q3 2024 | 38 | $29.1bn | 23 | 17 |
| Q4 2024 | 35 | $23.7bn | 18 | 19 |
| Q1 2025 | 36 | $20.8bn | 20 | 18 |
| Q2 2025 | 31 | $18.5bn | 18 | 13 |
| Q3 2025 | 36 | $19.0bn | 18 | 18 |
| Q4 2025 | 32 | $26.8bn | 25 | 19 |
| Q1 2026 | 30 | $28.9bn | 13 | 27 |
| Q2 2026 | 25 | $29.2bn | 14 | 24 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MRK and LLY →MRK and JNJ →MRK and VRTX →Choose a stock to compare with MRK →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MRK, latest filings →Back to the 13F Explorer →